(+98)21-26413024

(+98)21-26411650

FDA approves combination therapy Juvisync

FDA approves combination therapy Juvisync
The FDA has recently become aware of the potential for statins to increase blood sugar levels in patients with type 2 diabetes. This risk appears very small and is outweighed by the benefits of statins for reducing heart disease in diabetes.

FDA Approves Combivent Respimat Inhalation Spray

FDA Approves Combivent Respimat Inhalation Spray
Combivent Respimat is a suitable alternative for patients who are currently using Combivent (ipratropium bromide and albuterol sulfate) Inhalation Aerosol.

FDA approves Interrmezzo for insomnia

FDA approves Interrmezzo for insomnia
This is the first time the FDA has approved a drug for this condition. Intermezzo should only be used when a person has at least four hours of bedtime remaining. It should not be taken if alcohol has been consumed or with any other sleep aid.

FDA approves first generic version of cholesterol-lowering drug Lipitor

FDA approves first generic version of cholesterol-lowering drug Lipitor
The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).